Acarix AB Stock Nasdaq Stockholm
Equities
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- SEK | - |
Sales 2024 * | 86.9M 7.97M | Sales 2025 * | 191M 17.54M | Capitalization | 199M 18.23M |
---|---|---|---|---|---|
Net income 2024 * | -24M -2.2M | Net income 2025 * | 58M 5.32M | EV / Sales 2024 * | 2.24 x |
Net cash position 2024 * | 4M 367K | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.04 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
2.51
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.07% |
Latest transcript on Acarix AB
Managers | Title | Age | Since |
---|---|---|---|
Founder | 60 | 06-12-31 | |
Director of Finance/CFO | 60 | 15-12-31 | |
Jennifer Matson
CTO | Chief Tech/Sci/R&D Officer | 47 | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 51 | 21-05-10 | |
Ulf Rosén
BRD | Director/Board Member | 64 | 13-12-31 |
Director/Board Member | 70 | 21-05-10 |
1st Jan change | Capi. | |
---|---|---|
-15.28% | 18.56B | |
-46.16% | 2.71B | |
+17.00% | 1.85B | |
-0.51% | 1.66B | |
+25.65% | 1.22B | |
-13.90% | 989M | |
-21.76% | 896M | |
-19.12% | 660M | |
+6.37% | 490M |